Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 251 - 300 out of 3,148

Document Document Title
WO/2013/014659A1
Described are compounds of the structural formula (I): Also provided are pharmacologically acceptable isomers and salts of the compound of (I). The compounds are useful in the treatment of inflammatory bowel disease.  
WO/2013/000669A1
Fragrances having a fresh scent are usually very volatile and therefore not very economical in typical applications, such as washing or cleaning processes. Thus, said fragrances must be used in relatively large quantities, in order to br...  
WO/2012/167530A1
The present invention relates to a cleaning agent for a lubricating oil and the production process thereof, and a process method for producing an additive for a lubricating oil having a TBN of from about 100 to about 400, the process met...  
WO/2012/155368A1
A method for preparing 2, 5-dihydroxyterephthalic acid is provided. The raw material of 1, 4-dihalo-2, 5-dialkoxybenzene is converted to 2, 5-dialkoxyterephthalic acid via Grignard carboxylation, and 2, 5-dialkoxyterephthalic acid underg...  
WO/2012/117968A1
The problem addressed by the present invention is to provide a method for controlling the genesis and/or differentiation of an embryo by easily and rapidly controlling the obstruction of activation of the Wnt signal without using a genet...  
WO/2012/077673A1
Provided is a method for efficiently producing 4,5-dialkoxy-2-hydroxybenzoic acid from low-cost starting materials. Specifically provided is a method for producing 2-bromo-4,5-dialkoxy benzoic acid represented by general formula (2) (whe...  
WO/2012/066366A1
The invention relates to non-sulfonic acid type new rasagiline salts, a process for the preparation thereof, pharmaceutical compositions containing said salts and the use thereof for the treatment or prophylaxis of various diseases, name...  
WO/2012/060451A1
The invention provides a composition containing a chelating agent and un-heated cashew nutshell oil.  
WO/2012/055014A1
Phenylketone carboxylate compounds of Formula I, wherein n=2-6; R=C(0); -OC(O)- or -CH( OH)-; A is (CH2)mCOOH, W(CH2)mCOOH or YCH(COOH)((CH2)pCH3) when B is Ft B is (CH2)mCOOH, W(CH2)mCOOH or YCH(COOH)((CH2)pCH3) when A is Ft or A snd B ...  
WO/2012/011112A1
The present invention provides dihydro-CBD compounds of formula (I) and derivatives thereof, compositions comprising them and uses thereof in the manufacture of medicaments for the treatment of conditions, diseases, disorders or symptoms...  
WO/2011/160821A2
The present invention refers to joint mixtures of phenylbutyric acid or its ions and at least one organic molecule, like organic salts of phenylbutyrate, polymorphs, hydrates or solvates thereof and co-crystals of phenylbutyric acid and ...  
WO/2011/162351A1
The disclosed porous metal complex comprises a metal complex formed by the coordinate bonding of a trivalent metal ion with an aromatic tricarboxylic acid represented by formula (1). The porous metal complex has a microporous structure f...  
WO/2011/148520A1
Provided is a dispersant for non-aqueous dispersion media that can be used for a broad range of substances to be dispersed and which can exhibit excellent dispersion stability with small amounts added. The dispersant for non-aqueous disp...  
WO/2011/148660A1
Provided is a dispersant for non-aqueous dispersion media that can be used for a broad range of substances to be dispersed and which can exhibit excellent dispersion stability with small amounts added. The dispersant for non-aqueous disp...  
WO/2011/136513A2
Provided is a bone-transplant or bone-filling composition, which comprises a dihydroxybenzoic acid derivative which has been newly demonstrated to increase the activity of osteoblasts and so induce bone formation.  
WO/2011/128431A1
Disclosed are novel cross-linkable end-cappers for oligo-and polyimides. End-capped oligo-and polyimides comprising such an end-capper may be cured at a lower temperature compared to oligo-and polyimides end-capped with PEPA.  
WO/2011/105521A1
Disclosed is a metal complex having high adsorption properties, high gas occlusion properties and high gas separation properties. The general formula (I) is below; 【Chemical Formula 1】(in the formula, R1-R4 are as set forth in the de...  
WO/2011/089529A1
Fatty acid conjugates of salicylate derivatives and compositions thereof are disclosed. Further disclosed are methods for treating and/or preventing an inflammatory disease including inflammation and/or inflammatory bowel disease (IBD), ...  
WO/2011/089874A1
In order to provide a highly pure 1:2 clathrate of an aromatic carboxylic acid compound and an imidazole compound, and to provide an epoxy resin composition containing said clathrate as a curing agent or a curing promoter, it is possible...  
WO/2011/084726A1
A compound of formula: Pharmaceutical compositions containing the compound, and methods of inducing cytokine biosynthesis in an animal, treating a viral infection and/or treating a neoplastic disease in an animal by administering an effe...  
WO/2011/084725A1
A compound of formula:[ I ] Pharmaceutical compositions containing the compound, and methods of inducing cytokine biosynthesis in an animal, treating a viral infection and/or treating a neoplastic disease in an animal by administering an...  
WO/2011/037929A2
Pd (II) -catalyzed ortho-hydroxylat ion of variously substituted aromatic carboxylic acids under O2 or air is achieved under non-acidic conditions. Extensive labeling studies support a direct oxygenation of aryl C-H bonds with molecular ...  
WO/2011/028852A2
Fluorinated ethers of aromatic acids are produced from halogenated aromatic acids in a reaction mixture containing a copper (I) or copper (II) source and an amino acid ligand that coordinates to copper. The fluorinated ethers of aromatic...  
WO/2011/028866A2
Fluorinated ethers of aromatic acids are produced from halogenated aromatic acids in a reaction mixture containing a copper (I) or copper (II) source and a diketone ligand that coordinates to copper. The fluorinated ethers of aromatic ac...  
WO/2011/028872A2
Fluorinated ethers of aromatic acids are produced from halogenated aromatic acids in a reaction mixture containing a copper (I) or copper (II) source and a diamine ligand that coordinates to copper. The fluorinated ethers of aromatic aci...  
WO/2011/028851A2
New fluorinated ethers of aromatic acids and diesters are disclosed. These compositions can be applied to, e.g., fibers, yarns, carpets, garments, films, molded parts, paper and cardboard, stone, and tile to impart soil, water and oil re...  
WO/2011/028862A2
Fluorinated ethers of aromatic acids are produced from halogenated aromatic acids in a reaction mixture containing a copper (I) or copper (II) source and a Schiff base ligand that coordinates to copper. The fluorinated ethers of aromatic...  
WO/2011/007146A1
Compounds of formula (I) are suitable for use as herbicides: wherein R is methyl, ethyl, vinyl, ethynyl or cyclopropyl, R1 is hydrogen, C1-C6alkyl, C1-C6haloalkyl, C3-C7cycloalkyl, C1-C6alkoxy, C1-C6haloalkoxy, vinyl, propenyl, ethynyl, ...  
WO/2010/115252A9
The present invention relates to phthalimide derivatives of non-steroidal anti-inflammatory compounds and/or TNF-α modulators, to a method for producing these derivatives, to pharmaceutical compositions containing these derivatives, and...  
WO/2010/145800A1
The present invention relates to tramadol-diflunisal salts, processes for preparation of the same and their uses as medicaments or in pharmaceutical formulations, more particularly for the treatment of pain.  
WO/2010/144959A1
The present invention relates to analogues of anti-fibrotic agents having the formula (I) with the substituents as described within the specification. The present invention also relates to methods for their preparation.  
WO/2010/142124A1
Medicines with adamantane structure and their derivatives and analogues having new activity and indications such as antitumor, and their uses as medicine for treating some diseases such as tumor. The medicines are the compounds having th...  
WO/2010/139481A1
The invention relates to naphthalene derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonis...  
WO/2010/141334A1
A process for synthesis of a compound of Formula (X) wherein R1 is an aryl group substituted with one to three substituent groups, wherein each substituent group of R1 is independently C1-C5 alkyl, aminocarbonyl, alkylaminocarbonyl, dial...  
WO/2010/137943A1
The present invention discloses a composition comprising caffeoylshikimic acids, protocatechuic acid, hydroxytyrosol, hydroxybenzoic acid, said caffeoylshikimic acids and their derivatives extracted from any part of oil palm including bu...  
WO/2010/134477A1
Disclosed is a radiation-sensitive resin composition containing (A) an acid-dissociable group-containing resin and (C) a compound represented by general formula (1). In general formula (1), Z- represents a monovalent anion represented by...  
WO/2009/120215A9
A method for preparing an oxydiphthalic anhydride comprises contacting, under reactive and substantially anhydrous conditions in a reactor, at least one halophthalic anhydride containing more than 250 ppm chlorophthalide impurity with a ...  
WO/2010/116099A1
The invention relates to a method for preparing molecular complexes between Adapalene and cyclodextrins using the technology of dense fluids under pressure, especially that of CO2.  
WO/2010/117108A1
The present invention relates to a polyacetylene supramolecular sieve having selectivity for cationic or anionic compounds, and a chemical sensor for detecting cationic or anionic compounds using the same, and more specifically, the poly...  
WO/2010/094554A1
The invention relates to an improved method for releasing an organic acid, preferably a carbon, sulfone or phosphone acid, particularly an alpha or beta hydroxycarbon acid, from the ammonia salt thereof by releasing and removing ammoniac...  
WO/2010/094630A1
The invention relates to a method for converting ammonium salts of organic acids into the respective free organic acids, wherein an aqueous solution of the ammonium salt is brought into contact with an organic extraction agent, and the s...  
WO/2010/067622A1
Disclosed are compounds of 90% or higher purity and that are represented by only one or the other of formula (1) or formula (2), and compositions comprising compound (1) and compound (2) wherein the molar ratio of compound (1):compound (...  
WO/2010/067627A1
A compound represented by R-X, wherein R is a group represented by formula (1) and X is a halogen atom, hydroxy, an aryloxy, or a (meth)acrylic ester group represented by formula (5).  
WO/2010/043584A1
The invention relates to the use of and mainly novel compounds of the formula (I) wherein the moieties are as defined in the description, which are useful as farnesyl pyrophosphate synthase modulators and e.g. in the treatment of prolife...  
WO/2010/041748A1
Disclosed is a prophylactic or therapeutic agent for diabetes, diabetic complications, insulin resistance syndrome, metabolic syndrome, hyperglycemia, dyslipidemia, atherosclerosis, heart failure, cardiomyopathy, myocardial ischemia, cer...  
WO/2010/035561A1
Disclosed is a gas adsorbing material having a three-dimensional structure. The three-dimensional structure comprises an aromatic ring as a main skeleton. A ligand (p-hydroxybenzoic acid) containing a carboxyl group and a functional gr...  
WO/2010/011871A2
This disclosure relates to methods and compositions for modulating disease resistance in plants and transgenic plants.  
WO/2009/151082A1
Disclosed is a method by which the amount of residual intermediate product can be reduced and an aromatic polycarboxylic acid can be manufactured wherein all of the alkyl groups are converted into carboxy groups at a high yield. In the p...  
WO/2009/150927A1
Disclosed is a process for producing a liquid metal chelate compound that can produce a liquid metal chelate compound, which can be used directly or after dilution with water or the like, in a very simple manner in a short time in a larg...  
WO/2009/125606A1
Provided is a compound represented by formula (I) having a PAI-1 inhibiting action. [In formula (I), R1 represents an optionally substituted C6-10 aryl group etc., T represents a single bond etc., m is 0 or 1, when m is 0 G represents -N...  

Matches 251 - 300 out of 3,148